Peng Xia to Coronavirus Infections
This is a "connection" page, showing publications Peng Xia has written about Coronavirus Infections.
Connection Strength
0.076
-
Clinicopathological Features and Outcomes of Acute Kidney Injury in Critically Ill COVID-19 with Prolonged Disease Course: A Retrospective Cohort. J Am Soc Nephrol. 2020 09; 31(9):2205-2221.
Score: 0.028
-
Is there a role for blood purification therapies targeting cytokine storm syndrome in critically severe COVID-19 patients? Ren Fail. 2020 Nov; 42(1):483-488.
Score: 0.007
-
Single-cell landscape of immunological responses in patients with COVID-19. Nat Immunol. 2020 09; 21(9):1107-1118.
Score: 0.007
-
Immunological and inflammatory profiles in mild and severe cases of COVID-19. Nat Commun. 2020 07 08; 11(1):3410.
Score: 0.007
-
Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis. Cell Metab. 2020 08 04; 32(2):188-202.e5.
Score: 0.007
-
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. N Engl J Med. 2020 04 23; 382(17):e38.
Score: 0.007
-
Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19. Clin Immunol. 2020 05; 214:108408.
Score: 0.007
-
The persistent prevalence and evolution of cross-family recombinant coronavirus GCCDC1 among a bat population: a two-year follow-up. Sci China Life Sci. 2017 12; 60(12):1357-1363.
Score: 0.006